ANDREW STOLLMAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protagenic Therapeutics, Inc.\new

Filing Date Source Excerpt
2010-10-25 Includes 446,324 shares of common stock and 436,065 shares of Common Stock issuable upon the exercise of options held by Mr. Stollman.

Data sourced from SEC filings. Last updated: 2026-03-05